1. Ocular safety of Intravitreal Clindamycin Hydrochloride Released by PLGA Implants
- Author
-
Gabriella Fernandes-Cunha, Francine Behar-Cohen, Min Zhao, Gisele Rodrigues da Silva, Armando Silva-Cunha, Sílvia Ligório Fialho, Federal University of Minas Gerais (UFMG), Centre de Recherche des Cordeliers (CRC), Université Pierre et Marie Curie - Paris 6 (UPMC)-École pratique des hautes études (EPHE), Université Paris sciences et lettres (PSL)-Université Paris sciences et lettres (PSL)-Université Paris Diderot - Paris 7 (UPD7)-Université Paris Descartes - Paris 5 (UPD5)-Institut National de la Santé et de la Recherche Médicale (INSERM), Fundação Ezequiel Dias (FUNED), Faculty of Pharmacy, University Federal of São João Del Rei, Federal University of Minas Gerais ( UFMG ), Centre de Recherche des Cordeliers ( CRC ), Université Paris Diderot - Paris 7 ( UPD7 ) -École pratique des hautes études ( EPHE ) -Université Pierre et Marie Curie - Paris 6 ( UPMC ) -Université Paris Descartes - Paris 5 ( UPD5 ) -Institut National de la Santé et de la Recherche Médicale ( INSERM ), Ezequiel Dias Foundation Belo Horizonte, Universidade Federal de Minas Gerais = Federal University of Minas Gerais [Belo Horizonte, Brazil] (UFMG), HAL-UPMC, Gestionnaire, and Université Pierre et Marie Curie - Paris 6 (UPMC)-École Pratique des Hautes Études (EPHE)
- Subjects
0301 basic medicine ,genetic structures ,Interleukin-1beta ,Pharmaceutical Science ,Biocompatible Materials ,Pharmacology ,Cell morphology ,chemistry.chemical_compound ,Drug Delivery Systems ,0302 clinical medicine ,Polylactic Acid-Polyglycolic Acid Copolymer ,[SDV.MHEP.MI]Life Sciences [q-bio]/Human health and pathology/Infectious diseases ,Medicine ,Pharmacology (medical) ,PLGA ,Prostheses and Implants ,[SDV.SP]Life Sciences [q-bio]/Pharmaceutical sciences ,3. Good health ,[SDV.SP] Life Sciences [q-bio]/Pharmaceutical sciences ,[ SDV.MHEP.MI ] Life Sciences [q-bio]/Human health and pathology/Infectious diseases ,[SDV.MHEP.OS] Life Sciences [q-bio]/Human health and pathology/Sensory Organs ,[ SDV.MHEP.OS ] Life Sciences [q-bio]/Human health and pathology/Sensory Organs ,Intravitreal Injections ,Toxicity ,[SDV.MHEP.MI] Life Sciences [q-bio]/Human health and pathology/Infectious diseases ,Molecular Medicine ,Female ,Microglia ,intravitreal implant ,Neuroglia ,Biotechnology ,Ependymoglial Cells ,Retina ,Cell Line ,03 medical and health sciences ,biocompatibility ,In vivo ,Animals ,Humans ,Lactic Acid ,[SDV.MHEP.OS]Life Sciences [q-bio]/Human health and pathology/Sensory Organs ,Clindamycin Hydrochloride ,Interleukin-6 ,Tumor Necrosis Factor-alpha ,business.industry ,ocular toxoplasmosis ,Macrophages ,Organic Chemistry ,toxicity ,Retinal ,clindamycin ,eye diseases ,Rats ,Vitreous Body ,030104 developmental biology ,[ SDV.SP ] Life Sciences [q-bio]/Pharmaceutical sciences ,chemistry ,Rats, Inbred Lew ,030221 ophthalmology & optometry ,Implant ,sense organs ,business ,Polyglycolic Acid ,Ex vivo - Abstract
International audience; Background: Drug ocular toxicity is a field that requires attention. Clindamycin has been injected intravitreally to treat ocular toxoplasmosis, the most common cause of eye posterior segment infection worldwide. However, little is known about the toxicity of clindamycin to ocular tissues. We have previously showed non intraocular toxicity in rabbit eyes of poly(lactic-co-glycolic acid) (PLGA) implants containing clindamycin hydrochloride (CLH) using only clinical macroscotopic observation. In this study, we investigated the in vivo biocompatibility of CLH-PLGA implants at microscotopic, cellular and molecular levels.Methods: Morphology of ARPE-19 and MIO-M1 human retinal cell lines was examined after 72 h exposure to CLH-PLGA implant. Drug delivery system was also implanted in the vitreous of rat eyes, retinal morphology was evaluated in vivo and ex vivo. Morphology of photoreceptors and inflammation was assessed using immunofluorescence and real-time PCR.Results: After 72 h incubation with CLH-PLGA implant, ARPE-19 and MIO-M1 cells preserved the actin filament network and cell morphology. Rat retinas displayed normal lamination structure at 30 days after CLH-PLGA implantation. There was no apoptotic cell and no loss in neuron cells. Cones and rods maintained their normal structure. Microglia/macrophages remained inactive. CLH-PLGA implantation did not induce gene expression of cytokines (IL-1β, TNF-α, IL-6), VEGF, and iNOS at day 30.Conclusion: These results demonstrated the safety of the implant and highlight this device as a therapeutic alternative for the treatment of ocular toxoplasmosis.
- Published
- 2017